arrow
B

Bin Xu

Nanning Center for Disease Control and Prevention
H指数:29
被引数:2,506

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of Decitabine in Combination with IA Versus IA in Patients with Newly Diagnosed AML, a Multicenter, Prospective, Randomized Controlled Trial

新诊断AML患者中联合IA方案与单独IA方案对比去甲氧基柔红霉素的疗效:一项多中心、前瞻性、随机对照试验

BLOOD
IF23.1
2024-11-050
PRE
An atlas of genetic effects on cellular composition of the tumor microenvironment
2024-09-020
PRE
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies
MABS
IF7.3
2023-12-140
OAAI
Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms
2023-11-015
PRE
HSPA12A was identified as a key driver in colorectal cancer GWAS loci 10q26.12 and modulated by an enhancer-promoter interaction

HSPA12A被确定为结直肠癌gwa基因座10 q26.12的关键驱动因子,并受增强子-启动子相互作用的调节

2023-05-280
PRE
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
2023-05-0911
OAAI
Tumor radiomic features on pretreatment MRI to predict response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a multicenter study
2022-11-2811
OAAI